Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

PSA is a useful indicator of prostate cancer in finasteride-treated patients

Sep. 21, 1998

Preliminary analysis indicates good efficacy and safety of resiniferatoxin in urge incontinence

Sep. 18, 1998

New bladder-selective M3 antagonist from Yamanouchi for urinary urge incontinence

Sep. 18, 1998

New treatment for BPH discovered by Hungarian research team

Sep. 17, 1998

Bioniche receives EU registration for Cystistat

Sep. 16, 1998

Adrenergic agents for BPH described by Abbott in patent literature

Sep. 15, 1998

New agent for unstable bladder introduced in U.K.

Sep. 11, 1998

WAY-140288: a follow-up V2 antagonist and aquaretic agent from Wyeth-Ayerst

Aug. 28, 1998

Profile of VPA-985, Wyeth-Ayerst's aquaretic agent in clinical trials

Aug. 28, 1998

A-131701: a uroselective alpha-adrenergic agent for treatment of BPH

Aug. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.